
Cardglim M 1mg/500mg Tablet
Marketer
Innosearch Biotech
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Cardglim M 1mg/500mg Tablet
Glimepiride/Metformin 1mg/500mg tablets are classified as antidiabetic medications. This dual-agent formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic control. Continuous use is vital, even with well-managed blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications including nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are crucial in diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions necessitate physician consultation before commencing treatment. Pregnant or lactating individuals should seek medical advice. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.
Primary Ingredients of Cardglim M 1mg/500mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Cardglim M 1mg/500mg Tablet
Managing type 2 diabetes
Major Benefits of Cardglim M 1mg/500mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Cardglim M 1mg/500mg Tablet should be administered with a meal.
Common Side effects of Cardglim M 1mg/500mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Cardglim M 1mg/500mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Cardglim M 1mg/500mg tablets with a meal.
How Cardglim M 1mg/500mg Tablet works:
Cardglim M 1mg/500mg tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Cardglim M 1mg/500mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Cardglim M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Lactation is contraindicated with Cardglim M 1mg/500mg tablets due to potential infant toxicity.
DrivingCAUTION
Driving may be impaired by abnormally low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Cardglim M 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is necessary. The medication is contraindicated for individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Cardglim M 1mg/500mg tablets, as dose modification may be necessary. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; however, the medication is unsuitable for patients experiencing severe hepatic dysfunction.
What if you forget to take Cardglim M 1mg/500mg Tablet :
Should you forget a Cardglim M 1mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cardglim M 1mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
